fluorodeoxyglucose f18 has been researched along with Empyema in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheon, M; Choi, JY; Hyun, SH; Kim, H; Kim, J; Lee, KS; Shim, YM; Yoo, J; Zo, JI | 1 |
| Lin, EC; Studley, M | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Empyema
| Article | Year |
|---|---|
Diagnostic Performance of ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/CT for Chronic Empyema-Associated Malignancy.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Empyema; Female; Fistula; Fluorodeoxyglucose F18; Humans; Lymphoma, B-Cell; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2019 |
Biliary tract FDG uptake secondary to stent placement.
Topics: Biliary Tract; Biliary Tract Diseases; Biliary Tract Surgical Procedures; Cholangitis; Cholestasis, Extrahepatic; Empyema; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Pancreatic Neoplasms; Stents; Tomography, Emission-Computed | 2003 |